 LEK FARMACEVTSKA DRUŽBA D.D.
|
| Company: |
LEK FARMACEVTSKA DRUŽBA D.D.
|
| Address: |
Verovškova ulica 57, 1526 Ljubljana
|
Google maps
|
| Municipality: |
Ljubljana
|
| Region: |
Central Slovenia (Osrednjeslovenska)
|
| Contacts: |
 00386 15802111
 http://www.lek.si
 Robert Ljoljo
|
| Company management: |
President of the Management Board: Robert Ljoljo
Member of the Board: Andrej Pardo
Member of the Board: Ksenija Butenko Černe
Member of the Board: Marjan Novak
Member of the Board: Raul Napoleon Intriago Lombeida
Member of the Board: Uroš Urleb
Member of the Board: Andreja Bucik Primožič
|
| Extract of management responsible for a company's business operations abroad: |
Katja Razinger,
|
| Registration number: |
1732811
|
| Tax number: |
87916452
|
| Organisational form: |
Joint Stock Company
|
| Source of capital: |
Foreign
|
| Inter-company connections: |
Parent company: Novartis AG, Lichtstrasse 35, 4056 Basel, Switzerland
Subsidiary: Čistilna naprava Lendava d.o.o., Lendavska c. 30, 9220 Lendava - Lendva, Slovenia
Subsidiary: Sandoz d.d., Verovškova 57, 1000 LJUBLJANA, Slovenia
|
| Number of employees: |
5217
|
| Size of company: |
Large
|
| Income: |
1.667.133.616,00 €
|
| Exports share in income: |
96,00 %
|
| Tradition since: |
1946
|
| Total equity: |
1.259.147.462,00 €
|
| Total assets: |
1.673.538.818,00 €
|
| Representation of third party's trade marks and companies: |
Sandoz: distribution of Sandoz products
|
| Extract of target regions and countries where a company exports: |
Albania
Algeria
Argentina
Armenia
Australia
Austria
Azerbaijan
Bangladesh
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
Canada
Chile
China
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Estonia
Finland
France
Georgia
Germany
Ghana
Greece
Guatemala
Hong Kong Special Administrative Region of China
Hungary
Iceland
India
Indonesia
Iran (Islamic Republic of)
Ireland
Israel
Italy
Japan
Jordan
Kazakhstan
Kosovo
Kyrgyzstan
Latvia
Lebanon
Lithuania
Malaysia
Mexico
Mongolia
Montenegro
Morocco
Netherlands
New Zealand
Niger
Nigeria
North Macedonia
Norway
Pakistan
Panama
Philippines
Poland
Portugal
Republic of Korea
Republic of Moldova
Republic of South Africa
Romania
Russian Federation
Saudi Arabia
Serbia
Singapore
Slovakia
Southern Africa
Spain
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Thailand
Tunisia
Türkiye
Turkmenistan
Ukraine
United Arab Emirates
United Kingdom
United States
Uzbekistan
Viet Nam
|
| Description of company: |
Lek is one of the key pillars of the second-largest generic pharmaceutical company globally. Its role within Sandoz is to act as: a leading global development center for technologically demanding products and technologies; a key global manufacturing center for active pharmaceutical ingredients and medicines; a competence center for the development of vertically integrated products; a Sandoz competence center in the field of development and manufacturing of biosimilar active ingredients and products; a supply center for the markets of Central and Eastern Europe (CEE), South East Europe (SEE) and the Commonwealth of Independent States (CIS), and is responsible for marketing and sales of Sandoz products on the Slovenian market. For further information, please visit www.lek.si.
|
| Description of products and services: |
Lek is one of key pillars of the second-largest generic pharmaceutical company globally. Its role within Sandoz is to act as: a leading global development center for products and technologies; a global manufacturing center for active pharmaceutical ingredients and medicines; a competence center for the development of vertically integrated products; a Sandoz competence center in the field of development and manufacturing of biosimilar products; and, a supply center for the markets of Central and Eastern Europe (CEE), South East Europe (SEE) and Commonwealth of Independent States (CIS), and it is responsible for sales on the Slovenian market. For further information please visit http://www.lek.si/eng/.
|
| Keywords: |
Market keywords
05003005 Drug delivery and other equipment
06001015 Pharmaceutical Products / Drugs
|
| Classification of company: |
Main activity in accordance with the NACE classification
21.200 Manufacture of pharmaceutical preparations
Activities in accordance with the CPA classification
21.10.10 Salicylic acid, O-acetylsalicylic acid, their salts and esters
|
| Certificates: |
ECO-Management and Audit Scheme (EMAS)
Responsible care
|
| Field of activity: |
Chemical and Rubber
Healthcare and Medical Industry
|
| Credit rating information: |
|
| Information on the presentation card companies are obtained from surveys. Financial data are for the financial year 2022, last update 30.06.2023. |
| Last data update 22.04.2024. |